One Medical Group Stock

onemedical.comHealthcare / Healthcare providers & servicesFounded: 2007Funding to Date: $437.68MM

One Medical is the developer of a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to One Medical Group before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

One Medical Group Stock Price

Forge Price 1
Price no longer available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

One Medical Group Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
08/22/2018 Series I $250MM $xx.xx $1.5B The Carlyle Group
Price per Share
$xx.xx
Shares Outstanding
20,112,630
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
The Carlyle Group
12/08/2015 Series H $65MM $xx.xx $1.01B J.P. Morgan Asset Management, Google Ventures, Benchmark Capital, Oak Investment Partners, Redmile Group, Maverick Capital
Price per Share
$xx.xx
Shares Outstanding
7,444,827
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
J.P. Morgan Asset Management, Google Ventures, Benchmark Capital, Oak Investment Partners, Redmile Group, Maverick Capital
04/17/2014 Series G $44.97MM $xx.xx $678.13MM Redmile Group, Google Ventures, Benchmark Capital, Maverick Capital, Oak Investment Partners, DAG Ventures
Price per Share
$xx.xx
Shares Outstanding
6,829,076
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Redmile Group, Google Ventures, Benchmark Capital, Maverick Capital, Oak Investment Partners, DAG Ventures
03/22/2013 Series F $30MM $xx.xx $256.29MM Google Ventures, Benchmark Capital, DAG Ventures
Price per Share
$xx.xx
Shares Outstanding
11,695,449
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Google Ventures, Benchmark Capital, DAG Ventures
09/02/2011 Series E $20.16MM $xx.xx $139.42MM Benchmark Capital, Maverick Capital, Oak Investment Partners, DAG Ventures
Price per Share
$xx.xx
Shares Outstanding
12,509,305
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Benchmark Capital, Maverick Capital, Oak Investment Partners, DAG Ventures
05/19/2010 Series D $15.26MM $xx.xx $71.78MM DAG Ventures, Oak Investment Partners, Benchmark Capital
Price per Share
$xx.xx
Shares Outstanding
14,528,912
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DAG Ventures, Oak Investment Partners, Benchmark Capital
03/04/2009 Series C $8.09MM $xx.xx $37.44MM Benchmark Capital, Pinnacle Investors
Price per Share
$xx.xx
Shares Outstanding
8,763,634
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Benchmark Capital, Pinnacle Investors
11/06/2008 Series B $3.63MM $xx.xx $12.22MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
6,324,592
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
06/14/2007 Series A $565,000 $xx.xx $3.77MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,130,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors

One Medical Group stock FAQs

plusminus

Can you buy One Medical Group stock?

You can no longer buy One Medical Group stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy One Medical Group stock?

You can no longer buy One Medical Group stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell One Medical Group stock?

You can no longer sell stock of One Medical Group on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell One Medical Group stock?

You can no longer sell stock of One Medical Group on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is One Medical Group a public company?

One Medical Group is now a public company traded on NASDAQ with ticker ONEM.
plusminus

What is One Medical Group’s stock price?

The stock price of One Medical Group is $16.47 as of 2/22/23.
plusminus

What is One Medical Group’s stock ticker symbol?

The ticker symbol of One Medical Group is ONEM.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

One Medical Group investors also invested in these private companies

Leadership & Board

Leadership

Bjorn Thaler
Chief Financial Officer
Amir Dan Rubin
Chair, Chief Executive Officer & President
Kimber Lockhart
Chief Technology Officer
Rajneesh (Raj) Behal, MD, MPH
Chief Quality Officer
Doug Gunderson
SVP, Operations
Doug Sweeny
Chief Marketing Officer
Andrew Diamond, MD, PhD
Chief Medical Officer
John Singerling
Chief Network Officer
Jamie McLeod
SVP, One Medical for Business
Jenni Vargas
Chief Strategy Officer
Christine Morehead
Chief People Officer
Lisa Mango
General Counsel

Board

Mark S. Blumenkranz, M.D.
Kalen F. Holmes, Ph.D.
Freda Lewis-Hall, M.D.
David B. Singer
Paul R. Auvil
David P. Kennedy
Amir Dan Rubin
Bruce W. Dunlevie
Robert R. Schmidt

One Medical Group’s news and media highlights

The doctor’s office chain is one of a number of companies seeking to cut healthcare costs for employers.
Just as natural antibodies help your body find and fight microbial invaders, tailored research antibodies let scientists target and study cancer cells. But too many are poorly made, scientists say.
Trillions Have Been Redistributed from the American Workforce to the Healthcare Industry Creating An Economic Depression for the Middle Class The Washington Post and Vox have done excellent reporting that shows U.S. spends so much more than other countries for one simple reason -- price. The good news is that some [...]
In a searing investigation into the once lauded biotech start-up Theranos, Nick Bilton discovers that its precocious founder defied medical experts—even her own chief scientist—about the veracity of its now discredited blood-testing technology.
Updated on: Nov 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.